Advanced search
Publication Cover
Pathogens and Global Health Volume 109, 2015 - Issue 6
Submit an article Journal homepage
183
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera

Johnathan SheeleDepartment of Emergency MedicineUniversity Hospitals Case Medical Center & Case Western Reserve University, Cleveland, OH, USACorrespondence[email protected]
,
Jessica CartowskiEastern Virginia Medical School and Emergency Physicians of Tidewater, VA, USA
,
Angela DartInternational Health Programs Operation Blessing International, Virginia Beach, VA, USA
,
Arjun PoddarEastern Virginia Medical School Epidemiology-Biostatistics Research Support Core, VA, USA
,
Shikha GuptaUniversity of Virginia School of Medicine, VA, USA
,
Eric StashkoDepartment of Emergency MedicineBeth Israel Deaconess Medical Center, Boston, MA, USA
,
Bhaskara S. RaviEastern Virginia Medical School Epidemiology-Biostatistics Research Support Core, VA, USA
,
Crawford NelsonOperation Blessing International, Virginia Beach, VA, USA
&
Ajay GuptaDepartment of Computer ScienceOld Dominion University, Norfolk, VA, USA
 show all
Pages 275-282 | Published online: 11 Aug 2015

References

  • Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet. 2004;363:223–33.
  • Kean S. As cholera goes, so goes Haiti. Science. 2014;345:1266–8.
  • Sack DA, Sack RB, Chaignat CL. Getting serious about cholera. N Engl J Med. 2006;355:649–51.
  • Roy SK, Hossain MJ, Khatun W, Chakraborty B, Chowdhury S, Begum A, et al. Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial. BMJ. 2008;336:266–8.
  • Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. Cholera. Lancet. 2012;379:2466–76.
  • Blehaut H, Massot J, Elmer GW, Levy RH. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos. 1989;10:353–64.
  • Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther. 2012;12:395–410.
  • Riaz M, Alam S, Malik A, Ali SM. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial. Indian J Pediatr. 2012;79:478–82.
  • Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol. 2011;45(Suppl):S149–53.
  • Berni Canani R, Cucchiara S, Cuomo R, Pace F, Papale F. Saccharomyces boulardii: a summary of the evidence for gastroenterology clinical practice in adults and children. Eur Rev Med Pharmacol Sci. 2011;15:809–22.
  • McFarland LV. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 2010;16:2202–22.
  • Kligler B, Cohrssen A. Probiotics. Am Fam Physician. 2008;78:1073–8.
  • Feizizadeh S, Salehi-Abargouei A, Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics. 2014;134:e176–91.
  • Buts JP, De Keyser N. Interaction of Saccharomyces boulardii with intestinal brush border membranes: key to probiotic effects? J Pediatr Gastroenterol Nutr. 2010;51:532–3.
  • Brandão RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, Tropia MJ, et al. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol. 1998;64:564–8.
  • Dias RS, Bambirra EA, Silva ME, Nicoli JR. Protective effect of Saccharomyces boulardii against the cholera toxin in rats. Braz J Med Biol Res. 1995;28:323–5.
  • Czerucka D, Nano JL, Bernasconi P, Rampal P. Response to cholera toxin of two epithelial intestinal cell lines. Effect of Saccharomyces boulardii. Gastroenterol Clin Biol. 1989;13:383–7.
  • Vidon N, Huchet B, Rambaud JC. Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin. Gastroenterol Clin Biol. 1986;10:13–16.
  • Czerucka D, Rampal P. Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells. Dig Dis Sci. 1999;44:2359–68.
  • Czerucka D, Roux I, Rampal P. Saccharomyces boulardii inhibits secretagogue-mediated adenosine 3‘,5’-cyclic monophosphate induction in intestinal cells. Gastroenterology. 1994;106:65–72.
  • Ericsson CD, Tannenbaum C, Charles TT. Antisecretory and antiinflammatory properties of bismuth subsalicylate. Rev Infect Dis. 1990;12(Suppl 1):S16–S20.
  • Ericsson CD, Evans DG, DuPont HL, Evans DJ Jr, Pickering LK. Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis. 1977;136:693–6..

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.